Abstract SEF/IL-17R/CIKS/ACT1 homology (SEFIR) domain containing proteins, which include the IL-17 receptors and an adaptor protein Act1, have essential roles in vertebrate immunity. However, the molecular mechanisms of Act1 function remain largely unexplored. In this article, we employed an evolutionary analysis to discover novel structural and functional properties of Act1. Firstly, we have found that the previously identified helix-loophelix and Ufd2-box domains in human Act1 have relatively recent evolutionary origins in higher vertebrates. Zebrafish Act1, which lacks these domains, is unable to induce JNK phosphorylation and activate cytokine expression when expressed in human cells. Secondly, we have established that Act1-like proteins contain DEATH-domains in basal animals, such as Hydra and primitive chordates, but lack this domain in vertebrates. Finally, we have shown that Act1-TRAF6 interactions are conserved throughout vertebrate evolution: Act1 derived from zebrafish can bind to TRAF6 and activate NF-jB in human cells. Moreover, we have identified a novel highly conserved motif at the amino-terminus of Act1, which is critical for binding to TRAF6 and activating NF-jB-dependent gene expression. We propose a model of evolutionary changes in Act1-mediated signalling, which contributes to a better understanding of evolution of the vertebrate immunity.
Introduction
The SEF/IL-17R/CIKS/ACT1 homology (SEFIR) and tollinteracting region (TIR) (STIR) domain protein superfamily includes TIR-domain containing toll-like receptors (TLRs) and their adaptors, and SEFIR-domain containing interleukin-17 receptors (IL-17R) and their adaptor Act1 (Novatchkova et al. 2003) . In addition, the DUF1863 family of prokaryotic proteins is related to TIR and SEFIRdomain families (Spear et al. 2009 ).
The TIR domain containing proteins have essential roles in animal and plant innate immunity (Staal and Dixelius 2007; Takeda and Akira 2005) . They have also been found in other eukaryotic groups (Staal and Dixelius 2007) and are believed to be acquired from prokaryotes as a result of endosymbiosis (Spear et al. 2009 ). In bacteria, TIR domain proteins are implicated in homeostatic processes and also as virulence factors in pathogenic bacteria (Newman et al. 2006; Spear et al. 2009 ).
The SEFIR-domain containing proteins are crucial for mammalian adaptive immunity and have also been associated with many autoimmune diseases in mice and humans (Gaffen 2009 ). The SEFIRs are found throughout the animal kingdom and in prokaryotes (Novatchkova et al. 2003) with uncharacterised phylogenetic relationships among the SEFIR-containing proteins and an unknown ancestral root.
Of all the STIRs, only the TIR domain structure has been determined. It consists of a core five-stranded parallel Electronic supplementary material The online version of this article (doi:10.1007/s00239-011-9450-7) contains supplementary material, which is available to authorized users.
b-sheet that is surrounded by a bundle of five a-helices and functions as a homooligomerisation unit (Xu et al. 2000) . The evolutionarily conserved regions of TIR domains are clustered in Boxes 1-3 (Spear et al. 2009 ). The SEFIRdomains are predicted to be structurally similar to TIRs apart from Box 3 (Novatchkova et al. 2003) .
The TIR domain containing proteins normally engage TRAF6 ubiquitin ligase to activate downstream signalling pathways (Muroi and Tanamoto 2008; Sasai et al. 2010) . Similarly, IL-17 receptors signal via TRAF6 (Liu et al. 2009 ), which is critical for IL-17-induced transcription of inflammatory genes (Huang et al. 2007; Liu et al. 2009; Schwandner et al. 2000) . The exact mechanisms of TRAF6 recruitment to IL-17 receptors remain unknown. Upon ligand binding, the SEFIR-domain of the IL-17 receptor homotypically interacts with the SEFIR-domain of Act1 (Chang et al. 2006 ) located at its C-terminus. Other mapped domains of Act1 comprise: (1) a putative TRAF binding site at the N-terminus (Kanamori et al. 2002) ; (2) a helix-loop-helix (HLH) region (Li et al. 2000) ; and (3) an Ufd2-box (U-box) domain in the central region of the protein (Li 2008; Liu et al. 2009 ). The U-box domain was recently proposed to ubiquitinate TRAF6 (Liu et al. 2009 ).
HLH domains are common in eukaryotic transcription factors (Pires and Dolan 2010) . A typical HLH is 50-60 amino acids long consisting of a short basic region, followed by a region predicted to form two amphipathic a-helices separated by a loop (the HLH region) (Pires and Dolan 2010) . Bacteria also have similar domains, called helix-turn-helix domains (Santos et al. 2009 ), but the phylogenetic relationships with their eukaryotic counterparts are unclear.
U-box domains are structurally similar to RING fingers of ubiquitin ligases. The U-box core is not stabilized by cysteine residues chelating zinc ions like in RING fingers, but by an array of hydrogen bonds and salt bridges (Aravind and Koonin 2000) . U-box domains mediate ubiquitin transfer from E2 enzymes to their target proteins (Aravind and Koonin 2000) . For instance, the U-box domain at the C-terminus of HSP70 interacting protein mediates ubiquitin-dependent degradation of HSP70 chaperone substrates (Jiang et al. 2001) . Like any other E3, U-box proteins need to specifically recruit their targets.
In this study, we looked at the evolution of Act1-like proteins in the animal kingdom. We have established a recent evolutionary origin of the Act1 U-box and HLH domains. We have identified key differences between SEFIR-domains of Act1 type and IL-17 receptor type, and used cladistics to demonstrate that the two SEFIR types have been evolving as separate lineages. Remarkably, we found Act1-like proteins in basal animals like Hydra, Lottia and Trichoplax, and also in a primitive chordate Amphioxus, which in contrast to vertebrates also contains DEATH-domains akin to the TLR adaptor MyD88. Finally, we have identified a novel TRAF6 binding motif at the N-terminus of Act1 that is highly conserved across vertebrate species and is required for both the Act1-induced TRAF6 ubiquitination and the activation of the main downstream signalling pathways. We speculate how acquisition of the TRAF6 binding motif may have compensated for the loss of DEATH-domains in Act1 proteins of the vertebrate lineage.
Materials and Methods

Bioinformatics
Homology searches were performed using BLAST tool and genomic databases (NCBI server, http://www.ncbi.nlm. nih.gov/), using the amino acid sequence of human Act1 as an initial query to create a vertebrate Act1 alignment. To search for invertebrate Act1-like proteins, the SEFIRdomain sequences of zebrafish Act1 (DrAct1) and lancelet SEFIR1-2 (BfSEFIRs), found in the first search, were used as queries. All of the identified sequences used for alignments are listed in Electronic Supplementary Material. The sequence accessions are given in Table 1 .
Sequence alignments were performed using the ClustalW2.0 tool (EBI, www.ebi.ac.uk/clustalw). A radial cladogram of SEFIR-domains shown in Fig. 1 , based on the ClustalW2.0 alignment (Electronic Supplementary Material, pp. 1-2), was constructed using Dendroscope (Huson et al. 2007) .
Alternating exons were highlighted in the protein sequences (Electronic Supplementary Material) based on available ENSEMBL annotation (http://www.ensembl.org) or manual annotation using Sequence Viewer 2.8.6 (NCBI server). Transmembrane regions of putative IL17 receptors were predicted using TMHMM server v. 2.0 (CBS, Technical University, Denmark).
Reagents
Rabbit polyclonal antibodies against phospho-JNK (#9251), phospho-ERK1/2 (#9101), phospho-p38 (#9215) (all from Cell Signalling) and TRAF6 (sc-7221, Santa Cruz Biotech); mouse monoclonal antibodies against His-tag (70796-3, Novagen), against myc-tag (9E10 clone, Santa Cruz Biotech) or conjugated HA-HRP antibody (3F10 clone, Roche), protein G-Sepharose (GE Healthcare), antiactin (A5441) and anti-FLAG M2 (A8592) antibodies, pCMV-FLAG-BAP, FLAG peptide and anti-FLAG agarose (all from Sigma) were used. Act1 (TRAF3IP2) cDNAs were generated from mouse spleen or zebrafish gill total RNA and subcloned into pEAK8-myc vector. pEAK8-TRAF6 wild type and the C70A mutant are described elsewhere (Bloor et al. 2008 ).
Transfection and Reporter Assays
293ET cells were transfected in 96-well plates using Lipofectamine 2000 (Invitrogen). A mix of 10 ng/well of pEAK8-myc-Act1 expression construct and 10 ng/well pNF-jB-luc plasmid (Clontech) were co-transfected along with 10 ng/well pRL-TK Renilla luciferase (Promega) to normalize for DNA uptake. One day after the transfection, the cells were lysed and luciferase activities were measured in lysates using the Dual-Glo luciferase assay kit (Promega). Data is presented as mean ± SD from triplicate wells of a representative experiment.
Immunoprecipitation and Western Blotting 293 ET cells were lysed in IP buffer (150 mM NaCl, 0.1%. Triton-X100, 20 mM Tris-HCl (pH 7.4), 5 mM EDTA, proteinase inhibitors) and the post-nuclear supernatants were incubated for 2 h with myc antibody followed by 2 h incubation with protein G-Sepharose at 4°C. For ubiquitination assays, cell extracts were incubated for 2 h with anti-FLAG agarose at 4°C. After four washes in IP buffer, precipitates were eluted with SDS loading buffer or FLAG peptide (150 lg/ml in IP buffer), respectively. The eluates were separated by SDS PAGE using precast 4-12% denaturing gels (Invitrogen), immunoblotted and the protein bands were visualized using Amersham ECL detection system (GE Healthcare).
RNA Isolation and Real-Time PCR
Total RNA from cells transfected with pEAK8 constructs was purified using RNeasy mini kit (Qiagen), and cDNA was synthesized using oligo-dT primers and Superscript III reverse transcriptase (Invitrogen). Real time PCRs were performed in the 7900HT machine (Applied Biosystems) using Taqman primers specific for human RPLPO, IL-8, I-jBa and TNF-a genes according to the manufacturer's instructions (Applied Biosystems). Data from a representative experiment is shown as mean ± SD.
ELISA
Levels of IL-6 in culture supernatants were determined by ELISA (BD Pharmigen), according to the manufacturer's instructions. Absorbance was measured at 450 nm using a spectrophotometric plate reader (Labsystems Multiscan Biochromic). The data was analysed using program Ascent software (Thermo Labsystems). (Dunn et al. 2008; King et al. 2008) . Individual domains are shown as white boxes. DD DEATH domain HLH helix-loop-helix, SEFIR SEF and IL-17R, U-box Ufd2 box. b A radial cladogram of SEFIR-domain sequences showing the relationship between Act1 and IL-17R proteins in vertebrates. The cladogram also includes Act1-like SEFIR sequences from lancelets (Bf) and acorn worms (Sk). Abbreviations and sequence references are given in Table 1 . Alignments and sequences employed to build the cladogram can be found in Electronic Supplementary Material
Results
Evolution of Act1-Like Proteins in the Animal Kingdom
To explore an evolutionary history of Act1, we extracted the sequences of Act1 and related proteins belonging to the vertebrate taxa, a basal chordate Amphioxus, and outside the chordate phylum, acorn worms, using NCBI-assisted BLAST searches of genomic databases. We found that the SEFIR-domain was the most conserved and defining domain of Act1. The alignment of Act1 protein sequences from different groups of vertebrates determined that there was almost no similarity between the protein sequences outside the SEFIR-domain below Amniotes (Fig. 1a and data not shown).
Each Act1 species has been given a two-letter abbreviation corresponding to the genus/species name in Latin (Table 1) . Next, we constructed a radial cladogram reflecting sequence similarities between the SEFIR sequences of Act1 and IL-17 receptors (the only other proteins known to contain this domain) ( Fig. 1b ; Electronic Supplementary Fig. 1 ). The analysis demonstrated that the Act1 SEFIR-domains form a separate clade from IL-17R SEFIRs, with nematode and cnidarian IL-17R SEFIRs being at the base of the IL-17R branch of the cladogram (Fig. 1b) , suggesting that at least within the chordates, Act1 and IL-17Rs evolved in parallel without the SEFIRdomain exchange. In addition, the discovery of the SEFIRdomain containing IL-17R-like proteins and cytosolic Act1-adaptors in invertebrates indicates the possibility of functional IL-17R signalling outside the adaptive immunity.
Alignment of the SEFIR-domains showed multiple differences in the two SEFIR types (Electronic Supplementary Fig. 1 ). For instance, the vertebrate Act1 proteins have a conserved N-G motif, next to the first SEFIR alpha-helix, predicted previously (Novatchkova et al. 2003) , which is present as an E/Q/W-G motif in lancelets (BfSEFIRs) and acorn worms (SkSEFIR). This motif changed to N-R in a degenerate sedimentary chordate, the tunicate Ciona (CiAct1). In contrast, the vertebrate IL-17R SEFIR-domains have a semi-conserved C-G motif in the corresponding position. Secondly, the last alpha-helix of SEFIRs contains a conserved W-P motif in vertebrate Act1 and the related lancelet and acorn worm SEFIRs, but the corresponding motif in IL-17 SEFIR-domains is present as L-M.
The differences between the two types of SEFIRdomains can assist with tracking down the two lineages and their phylogentic relationships in more distantly related invertebrate species and even in prokaryotes. For example, using the SEFIR-domain sequences from lancelets (BfSE-FIR1-2), we found four more predicted Act1-like proteins (BfSEFIR3-6) encoded within one gene cluster, which contain the N-G motif and a G-P motif in place of W-P as is the case in vertebrate Act1 and BfSEFIR1-2 (Electronic Supplementary Fig. 2) . Surprisingly, two of the newly found proteins (BfSEFIR5-6) contain DEATH-domains, also found in the TLR adaptors MyD88 and TIRAP (Yamamoto et al. 2004) . Additional sequence homology searches identified Act1-like proteins with both SEFIR and DEATH-domains in Hydra (Hydrozoa) and Trichoplax (Placozoa), the animals belonging to the most basal Metazoan taxa (Fig. 1a) . In the Trichoplax SEFIR-domain, we have also found the above-mentioned F-G (a changed N-G) and W-P motifs (Electronic Supplementary Fig. 1 ). We could not detect any Act1-like SEFIRs in Nematoda and Athropoda, but we have found a single DEATHdomain-containing SEFIR in Lottia gigantea (Mollusca) ( Fig. 1a; Electronic Supplementary Fig. 2) .
Next, we inspected the protein sequences outside the Act1 SEFIR-domain. The recently discovered U-box domain of Act1 is located between the HLH and SEFIRdomains (Fig. 1a) . The U-box of Act1 does not appear to be conserved and is encoded within a single exon, found only in birds and mammals. In mammals, we also found a motif of an unknown function next to a putative HLH domain (Fig. 1a) , DTGYDSQPQDVLG, which is encoded within the first and the largest exon of Act1 (Electronic Supplementary Fig. 3 ). This motif was also detected in frogs, but not in fish or invertebrates.
Species-Specific Protein Domains are Required for Act1-Induced Gene Expression in Human Cells
To examine the functional properties of various Act1 domains, we cloned Act1 from mouse (MmAct1) and human (HsAct1) cells, as well as from a zebrafish Danio rerio (DrAct1), which lacks the HLH and U-box domains. The three Act1 proteins were expressed in human 293 ET cells and their ability to induce endogenous IL-6 expression and mitogen-activated protein kinase (MAPK), JNK and p38, and NF-jB signalling was compared (Fig. 2) . Act1 is known to activate both NF-jB and MAPK in overexpression systems (Leonardi et al. 2000; Li et al. 2000; Liu et al. 2009 ), as a high cytosolic concentration is able to mimick the IL-17-induced Act1 clustering and recruitment of TRAF6, an important upstream mediator of Act1 signalling (Schwandner et al. 2000) . Similar to its human or murine counterparts, ectopically expressed DrAct1 was capable of activating the luciferase genereporter construct driven by a synthetic promoter containing several NF-jB binding sites (Fig. 2a) and inducing phosphorylation of p38 MAP kinase (Fig. 2b) . In addition, DrAct1 recruited TRAF6 (Fig. 2c) . However, both mammalian Act1 proteins, but not DrAct1, activated IL-6 gene J Mol Evol (2011) 72:521-530 525 expression and JNK phosphorylation (Fig. 2b, d ). Thus, TRAF6 binding and NF-jB activation are necessary but not sufficient to trigger Act1-dependent expression of IL-6. The remaining required signals may be mediated by the HLH and U-box domains lacked by zebrafish Act1, or via other domains yet to be determined.
A Novel TRAF6 Binding Motif is Located at the NTerminus of Act1
Previous studies have mapped two putative TRAF6 binding motifs within Act1: (1) PEEESE at the N-terminus of Act-1 and (2) EEERPA in the middle part of the protein (Kanamori et al. 2002; Li 2008) . The PEEESE motif does not appear to be conserved in Amniotes (Fig. 3a and Electronic Supplementary Fig. 3 ). The EEERPA motif lies in the recently described U-box ubiquitin-binding domain of Act1 (amino acids 268-330) (Liu et al. 2009 ) and is not required for Act1 binding to TRAF6, since the 1-256 aa mutant of Act1, lacking both the U-box and SEFIR-domains can still interact with TRAF6 (Kanamori et al. 2002) . Surprisingly, we have discovered another motif at the very N-terminus of Act1, PVEVDE, which fits the described consensus for TRAF6 binding sequence PxD/ExxD/E (Ye et al. 2002) . Moreover, the presence of an N-terminal TRAF6 binding motif is a highly conserved feature in vertebrates: in Amniotes the motif is PVEDVE, while in frogs and fish the sequence is PEENDE (Fig. 3a) .
To examine which TRAF6 binding site was important for TRAF6 binding, we generated several deletion and point mutants of Act1 (Fig. 3b) and expressed them in 293 ET cells. Deletion of the first 11 N-terminal amino acids of Act1 resulted in a loss of TRAF6 binding (12-555a); the same effect was observed when the newly found PVEVDE motif (T6BM) within this small region was mutated (Fig. 3c) . However, mutation of the previously described PEEESE motif (P3E ? 3A) (Kanamori et al. 2002) or deletion of the SEFIR-domain (1-400 aa) did not impair Act1-TRAF6 interaction (Fig. 3c) . These data show that the PVEVDE motif is a true TRAF6 binding motif within Act1, whereas the previously proposed PEEESE site is dispensable for Act1-TRAF6 interactions.
One of the important signalling events downstream of the IL-17 receptor is Act1-induced ubiquitination (Liu et al. 2009 ). To examine if Act1-TRAF6 binding is important for this phenomenon, we set up a ubiquitination assay in 293 ET cells, using TRAF6 as the ubiquitination target. As expected, wild type Act1 could induce the kinases, JNK and p38, for myc and actin as a loading control. c Total protein lysates of 293ET cells expressing myc-tagged zebrafish Act1 or human NF-jB p50 subunit (control) were immunoprecipitated using an anti-myc antibody. Lysates and precipitates (IP) were blotted for TRAF6 and myc. d 293 ET cells were transfected with plasmids encoding murine (Mm, Mus musculus), human (Hs, Homo sapiens) and zebrafish (Dr, Danio rerio) Act1 proteins. Induction of IL-6 gene expression was measured at mRNA level in cell lysates and at protein level in culture supernatants by qPCR and ELISA, respectively. The data is shown as the mean ± SD of a representative of three independent experiments, each conducted in duplicate ubiquitination of the endogenous TRAF6 (Fig. 3d) . Expression of the T6BM and 12-555 aa variants of Act1 failed to trigger the ubiquitination (Fig. 3d) . Therefore, Act1-induced ubiquitination is dependent on the TRAF6-Act1 interaction.
Act1-TRAF6 Binding is Essential for Act1-Induced Signalling and Gene Expression TRAF6-mediated activation of NF-jB has been extensively studied (Cao et al. 1996; Chen 2005) . In addition to NF-jB activation, TRAF6 is also known to mediate MAPK activation downstream of cytokine and pattern recognition receptors (Kobayashi et al. 2004) . We hypothesised that Act1 activates NF-jB and MAPK signalling via its interaction with TRAF6. First, we expressed wild type and mutant variants of Act1 together with a luciferase genereporter construct driven by a synthetic promoter containing several NF-jB binding sites. Ectopic expression of the wild type Act1 protein in 293 ET cells resulted in strong NF-jB activation (Fig. 4a) . Mutation or deletion of the PVEVDE motif of Act1 dramatically reduced the activity of the reporter construct (Fig. 4a) . However, mutation of the PEEESE site had no effect on Act1-induced reporter activation.
To explore whether TRAF6 binding is also needed for Act1-induced MAPK activation, the wild type and mutant forms of Act1 were expressed in 293 ET cells, and phosphorylation of MAPK was analysed by Western blotting using phospho-specific antibodies against c-Jun-N-terminal kinase (JNK), p38 and extracellular signal-regulated kinase 1/2 (ERK1/2) proteins. Act1 expression induced phosphorylation A B C D Fig. 3 Identification of a novel TRAF6 binding motif in Act1. of JNK and p38 but not ERK1/2 (Fig. 4b) . Mutation of the PVEVDE TRAF6 binding motif or deletion of the SEFIRdomain abrogated the MAPK activating potential of Act1.
To further validate these findings, the expression of endogenous inhibitor of NF-jB (IjBa), TNF-a and IL-8 were examined using RT-PCR. As expected, the expression of the above-mentioned NF-jB-dependent genes was induced by wild type Act1 but not by the mutant (Act1 T6BM) that failed to bind TRAF6 (Fig. 4c) . The related PEENDE motif in the N-terminus of DrAct1 is also functional; the deletion mutant lacking this motif (DrAct1 20-398) was unable to bind TRAF6 and activate NF-jB reporter (Electronic Supplementary Fig. 4) . Thus, our data indicates that Act1 relies on TRAF6 binding to the newly identified evolutionarily conserved PVEVDE motif to activate NF-jB and MAPK pathways.
Discussion
Mammalian SEFIR-domain containing proteins, IL-17R and Act1/CIKS, have received a lot of attention from immunologists because of their crucial functions in anti-bacterial immunity and involvement in autoimmune diseases (Huang et al. 2007; Qian et al. 2007 ). However, how these proteins evolved as a part of our immunome remains unexplored. In this study, we investigated the evolutionary history of Act1 and related proteins. By looking at the most conserved Act1 domain, SEFIR, we have traced Act1-related SEFIR-domain proteins in the most basal animals. We describe major differences between the SEFIR-domains of Act1 and related IL-17 receptors and show that at least in chordates these protein families have been evolving as two separate lineages without SEFIR-domain exchange. In addition, we have found that two IKB-α mRNA, fold induction Act1 Fig. 4 Act1-TRAF6 interaction is essential for Act1-induced NF-jB and MAPK activation. a Cells were co-transfected with a luciferase gene reporter driven by 49 NF-jB binding sites (NF-jB-luc) and the plasmids encoding for control protein BAP or Act1 wild type and mutant forms (as in Fig. 3 ). The cells were lysed, and the luciferase activities were measured. The data is shown as the mean ± standard deviation (SD) of a representative of three independent experiments, each conducted in triplicate. b Total protein lysates of 293ET cells expressing wild type and mutant Act1 proteins (as in Fig. 3) were blotted for the presence of phosphorylated MAP kinases: JNK, p38 and ERK1/2. c Total RNA was isolated from cells expressing wild type and mutant Act1 proteins (as in Fig. 3 When we aligned vertebrate Act1 sequences, we noticed a conserved region at the amino-terminus of the proteins encompassing the residues PVEVDE. The region corresponds to a known TRAF6 binding consensus and is required for TRAF6 binding. At the time of this manuscript being prepared, a study was published showing an association between the Act1 gene TRAF3IP2 and psoriatic arthritis and psoriasis (Huffmeier et al. 2010) . One of the Act1 variants described in that study has a missense mutation, D10N, and was shown to be deficient in TRAF6 binding in a mammalian two-hybrid system. Interestingly, this D10N mutation lies within the novel-conserved TRAF6 binding PVEDVE motif identified here, which further validates our findings.
We also demonstrate that the PVEVDE motif is important for Act1-induced TRAF6 ubiquitination. Earlier studies demonstrated that another domain of Act1, the U-box, is essential for Act1-triggered TRAF6 ubiquitination (Liu et al. 2009 ). Act1 U-box has only been recently acquired by vertebrates; it is encoded within a single exon acquired and are not detectable below frogs. It would be interesting to elucidate the origin of this domain and the driving force behind its appearance in vertebrate Act1.
Evolutionary conservation of TRAF6 binding sites is a broad phenomenon according to our analyses conducted using the NCBI BLAST engine. Similarly to Act1, the TRAF6 binding site of CD40 (Ye et al. 2002 ) is conserved in vertebrates; while in the case of the NF-jB ligand (RANKL) and IL-1 receptor-associated kinase 1 (IRAK1), which have several redundant TRAF6 binding sites, at least one of the sites always remains conserved (data not shown).
To summarise our findings, we propose a model of evolutionary changes in Act1-mediated signalling (Fig. 5) . Act1 can be compared with TLR adaptors MyD88 and TRIF in terms of its signalling function. In vertebrates, Act1 mediates signalling via a direct binding to TRAF6, which is similar to TRIF connecting TLR3 and TRAF6. MyD88 signals in a different way, recruiting TRAF6 indirectly, and associates with IRAK1 via a DEATH-domain-mediated homotypic interaction. IRAK1 can in turn recruit TRAF6 via its own TRAF6 binding sites. Interestingly, in invertebrates and lancelets, we have found DEATH-domain containing Act1-like proteins with domain architecture reminiscent of MyD88. We could not detect any sequences in these DEATH/SEFIR proteins matching the TRAF6 binding consensus. It is possible that the ancestral Act1-like proteins may signal in a similar way to MyD88 by recruiting IRAK kinases, which would provide a required link to TRAF6. It is exciting to speculate an evolutionary trend to combine both receptor and TRAF6 binding properties in one adaptor, such as Act1 and the TLR3 adaptor TRIF, which in vertebrates can both signal via TRAF6 independently of IRAK1 (Chang et al. 2006; Jiang et al. 2003) .
On the whole, the remarkably wide occurrence of Act1-like and IL-17R-like molecules in invertebrates poses an important question: what could be the possible function of the IL-17 signalling in animals lacking adaptive immunity? 
